Association between retinoid-X receptor-gamma genetic polymorphisms and diabetic retinopathy

Genetics and Molecular Research

Volumn 10, Issue 4, 2011, Pages 3545-3551

  Hsieh, C H ^a   Pei, D ^b   Hung, Y J ^a   Hsiao, F C ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Diabetic retinopathy; Single nucleotide polymorphism; Type 2 diabetes

Indexed keywords

CREATINE; GLUCOSE; NITROGEN; RETINOID X RECEPTOR GAMMA;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NITROGEN URINE LEVEL; RISK FACTOR; RXR GAMMA GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; TAIWANESE; AGED; ALLELE; DEMOGRAPHY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; STATISTICAL MODEL; TAIWAN;

ADULT; AGED; ALLELES; DEMOGRAPHY; DIABETIC RETINOPATHY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RETINOID X RECEPTOR GAMMA; TAIWAN;

EID: 84864379855     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2011.December.5.4     Document Type: Article

References (25)

1. Anonymous (1997). Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. Diabetes 46: 1829-1839.
2. Anonymous (1998a). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study Group. Lancet 352: 837-853.
3. Anonymous (1998b). Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 317: 703-713.
4. Awata T, Inoue K, Kurihara S, Ohkubo T, et al. (2002). A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 51: 1635-1639.
5. Buraczynska M, Ksiazek P, Baranowicz-Gaszczyk I and Jozwiak L (2007). Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetes patients. Nephrol. Dial. Transplant. 22: 827-832.
6. Cahill GF Jr, Etzwiler LD and Freinkel N (1976). Editorial: "Control" and diabetes. N. Engl. J. Med. 294: 1004-1005.
7. Chai D, Wang B, Shen L, Pu J, et al. (2008). RXR agonists inhibit high-glucose-induced oxidative stress by repressing PKC activity in human endothelial cells. Free Radic. Biol. Med. 44: 1334-1347.
8. Chen Y, Huang H, Zhou J, Doumatey A, et al. (2007). Polymorphism of the endothelial nitric oxide synthase gene is associated with diabetic retinopathy in a cohort of West Africans. Mol. Vis. 13: 2142-2147.
9. Davies PJ, Berry SA, Shipley GL, Eckel RH, et al. (2001). Metabolic effects of rexinoids: tissue-specific regulation of lipoprotein lipase activity. Mol. Pharmacol. 59: 170-176.
10. Fong DS, Aiello L, Gardner TW, King GL, et al. (2003). Diabetic retinopathy. Diabetes Care 26: 226-229.
11. Fujisawa T, Ikegami H, Kawaguchi Y, Hamada Y, et al. (1998). Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia 41: 47-53.
12. Hsieh CH, Liang KH, Hung YJ, Huang LC, et al. (2006). Analysis of epistasis for diabetic nephropathy among type 2 diabetic patients. Hum. Mol. Genet. 15: 2701-2708.
13. Juutilainen A, Lehto S, Ronnemaa T, Pyorala K, et al. (2007). Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women. Diabetes Care 30: 292-299.
14. Kastner P, Mark M and Chambon P (1995). Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life? Cell 83: 859-869.
15. Klein R, Klein BE, Moss SE, Davis MD, et al. (1984a). The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch. Ophthalmol. 102: 520-526.
16. Klein R, Klein BE, Moss SE, Davis MD, et al. (1984b). The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch. Ophthalmol. 102: 527-532.
17. Knowler WC, Coresh J, Elston RC, Freedman BI, et al. (2005). The family investigation of nephropathy and diabetes (FIND): design and methods. J. Diabetes Complications 19: 1-9.
18. Lesile RD and Pyke DA (1982). Diabetic retinopathy in identical twins. Diabetes 31: 19-21.
19. Mangelsdorf DJ and Evans RM (1995). The RXR heterodimers and orphan receptors. Cell 83: 841-850.
20. Parving HH, Tarnow L and Rossing P (1996). Genetics of diabetic nephropathy. J Am. Soc. Nephrol. 7: 2509-2517.
21. Ray D, Mishra M, Ralph S, Read I, et al. (2004). Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes. Diabetes 53: 861-864.
22. Reiner AP, Agardh E, Teramura G, Gaur P, et al. (2003). Diabetes duration may modify the association between genetic variation in the glycoprotein Ia subunit of the platelet collagen receptor and risk of severe diabetic retinopathy: a working hypothesis. Thromb. Haemost. 89: 142-148.
23. Roy MS, Hallman DM, Fu YP, Machado M, et al. (2009). Assessment of 193 candidate genes for retinopathy in African Americans with type 1 diabetes. Arch. Ophthalmol. 127: 605-612.
24. Shulman AI and Mangelsdorf DJ (2005). Retinoid x receptor heterodimers in the metabolic syndrome. N. Engl. J. Med. 353: 604-615.
25. Suganthalakshmi B, Anand R, Kim R, Mahalakshmi R, et al. (2006). Association of VEGF and eNOS gene polymorphisms in type 2 diabetic retinopathy. Mol. Vis. 12: 336-341.